Out of a library with billions of artificial antibodies, researchers
have identified ten that can possibly prevent cancer tumours from
growing.
A research team at Aarhus University i Denmark has developed ten new
antibodies that can possibly be used in the battle against cancer. They
work by inhibiting the body's blood vessel formation close to the
tumour, which is thereby cut off from oxygen and nutrient supply.
Up to now, the researchers have tested some of the antibodies on
mice and, in the laboratory they have succeeded in using them to stop
the development of malignant tumours.
"The antibodies we've found prevent a cancer tumour from growing. They
appear to work perfectly in the laboratory, and this means, of course,
that they've got incredibly interesting therapeutic potential that we'll
investigate further. However, we're still quite early in the
experimental stage," says Associate Professor Peter Kristensen.
The antibodies neutralize the effects of signal substances released
by carcinoma cells to get blood vessels to replicate, thus cutting off
the blood supply to the tumor.
A cancer tumor deprived of oxygen and nutrients becomes dormant
and is thereby made harmless. If it receives a supply from the
bloodstream, however, it grows and spreads, and the researchers appear
to be able to prevent this deadly process.
The researchers isolated their antibodies from a library consisting of
billions of different antibodies, and they subsequently analyzed the
ability of the individual antibodies to inhibit blood vessel formation.
This sounds like incredibly extensive laboratory work, and it would have
been far from possible just a few years ago. However, they used a
biological technology for this purpose that they developed and published
in Nature Protocols three years ago. It helps them to identify and
extract the antibodies with specific binding properties regarding the
surface proteins in blood vessel cells.
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
No comments:
Post a Comment